This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Medregen, LLC. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: John Sun: Innovator in Pharmaceutical Formulations
Introduction
John Sun is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of innovative methods and kits for improved stability of active ingredients.
Latest Patents
John Sun holds 1 patent related to formulations, methods, kits, and dosage forms. His patent focuses on the combination of at least two active ingredients, specifically AMD3100, a stem cell mobilizer, and Tacrolimus, a derivative or analog of FK506. The formulations are designed for administration as a single dose subcutaneous injection and may be beneficial in treating various diseases, disorders, or injuries.
Career Highlights
John Sun is currently associated with Medregen, LLC, where he applies his expertise in pharmaceutical innovations. His work emphasizes the importance of stability in drug formulations, which is crucial for effective treatment outcomes.
Collaborations
John collaborates with talented coworkers, including Isaac Agyemang and Rachel Labell, who contribute to the innovative environment at Medregen, LLC.
Conclusion
John Sun's contributions to pharmaceutical formulations highlight his role as an inventor dedicated to improving treatment methods. His innovative work continues to pave the way for advancements in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile